Huijbregts Richard P H, Michel Katherine G, Hel Zdenek
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA; Center for AIDS Research, University of Alabama at Birmingham, Birmingham, AL, USA.
Contraception. 2014 Aug;90(2):123-9. doi: 10.1016/j.contraception.2014.02.006. Epub 2014 Feb 26.
The potential effect of hormonal contraception on HIV-1 acquisition and transmission represents an important public health issue. Several observational studies have suggested an association between the use of hormonal contraception, in particular injectable depot medroxyprogesterone acetate (DMPA), and an increased risk of HIV-1 acquisition and transmission. We and others have previously demonstrated that DMPA acts as a potent inhibitor of innate and adaptive immune mechanisms. The study presented here addresses the immunomodulatory properties of several common progestins with a potential to replace DMPA.
To identify safe alternatives to DMPA, we tested the effect of commonly used progestins on the function of human primary T cells and plasmacytoid dendritic cells (pDCs) obtained from the blood of healthy premenopausal women.
Medroxyprogesterone acetate (MPA) inhibited the activation of T cells and pDCs in response to T cell receptor- and Toll-like receptor-mediated activation at physiological concentrations. Etonogestrel exerted a partial suppressive activity at high concentrations. In sharp contrast, norethisterone (NET) and levonorgestrel (LNG) did not exhibit detectable immunosuppressive activity.
Evidence indicating the immunosuppressive properties of DMPA strongly suggests that DMPA should be discontinued and replaced with other forms of long-term contraception. Since NET and LNG do not exert immunosuppressive properties at physiological concentrations, these progestins should be considered as alternative contraceptives for women at high risk for HIV-1 infection.
The presented data suggest that, at physiological levels, the progestins NET and LNG do not suppress cytokine production by immune cells and should be considered as alternatives to DMPA; however, more in vivo testing is needed to confirm this data.
激素避孕对HIV-1感染和传播的潜在影响是一个重要的公共卫生问题。多项观察性研究表明,使用激素避孕,尤其是注射用醋酸甲羟孕酮(DMPA),与HIV-1感染和传播风险增加之间存在关联。我们和其他人之前已经证明,DMPA是先天性和适应性免疫机制的有效抑制剂。本文介绍的研究探讨了几种可能替代DMPA的常见孕激素的免疫调节特性。
为了确定DMPA的安全替代品,我们测试了常用孕激素对从健康绝经前女性血液中获得的人原代T细胞和浆细胞样树突状细胞(pDC)功能的影响。
醋酸甲羟孕酮(MPA)在生理浓度下可抑制T细胞和pDC对T细胞受体和Toll样受体介导的激活的反应。依托孕烯在高浓度下具有部分抑制活性。形成鲜明对比的是,炔诺酮(NET)和左炔诺孕酮(LNG)未表现出可检测到的免疫抑制活性。
表明DMPA具有免疫抑制特性的证据强烈表明,应停用DMPA并改用其他形式的长效避孕方法。由于NET和LNG在生理浓度下不具有免疫抑制特性,这些孕激素应被视为HIV-1感染高危女性的替代避孕药。
所呈现的数据表明,在生理水平上,孕激素NET和LNG不会抑制免疫细胞产生细胞因子,应被视为DMPA的替代品;然而,需要更多的体内试验来证实这些数据。